Samuel John

1.3k total citations
22 papers, 379 citations indexed

About

Samuel John is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Samuel John has authored 22 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Public Health, Environmental and Occupational Health and 7 papers in Immunology. Recurrent topics in Samuel John's work include CAR-T cell therapy research (11 papers), Immune Cell Function and Interaction (7 papers) and Acute Lymphoblastic Leukemia research (7 papers). Samuel John is often cited by papers focused on CAR-T cell therapy research (11 papers), Immune Cell Function and Interaction (7 papers) and Acute Lymphoblastic Leukemia research (7 papers). Samuel John collaborates with scholars based in United States, India and Spain. Samuel John's co-authors include Mi Deng, Heyu Chen, Guojin Wu, Cheng Cheng Zhang, Xunlei Kang, Jaehyup Kim, Hiep Phan, Ningyan Zhang, Zhiqiang An and Xun Gui and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Samuel John

21 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel John United States 7 231 159 99 75 38 22 379
Rosanna M. McEwen-Smith United Kingdom 5 336 1.5× 159 1.0× 111 1.1× 118 1.6× 26 0.7× 5 482
Giulia Barbarito Italy 5 282 1.2× 208 1.3× 70 0.7× 127 1.7× 27 0.7× 11 415
Tina Nuebling Germany 9 270 1.2× 247 1.6× 132 1.3× 106 1.4× 17 0.4× 13 455
Soyoko Morimoto Japan 13 209 0.9× 188 1.2× 196 2.0× 31 0.4× 21 0.6× 37 388
Haven R. Garber United States 9 103 0.4× 162 1.0× 82 0.8× 45 0.6× 42 1.1× 20 245
Jine Zheng China 10 150 0.6× 175 1.1× 95 1.0× 156 2.1× 18 0.5× 20 395
Guillermo O. Rangel Rivera United States 10 169 0.7× 185 1.2× 117 1.2× 22 0.3× 41 1.1× 18 337
Susann Rahmig Germany 7 129 0.6× 76 0.5× 158 1.6× 123 1.6× 64 1.7× 9 341
Kirsten Nikolajsen Denmark 11 301 1.3× 213 1.3× 126 1.3× 52 0.7× 38 1.0× 15 401
Kyogo Suzuki Japan 6 80 0.3× 185 1.2× 167 1.7× 69 0.9× 44 1.2× 15 333

Countries citing papers authored by Samuel John

Since Specialization
Citations

This map shows the geographic impact of Samuel John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel John more than expected).

Fields of papers citing papers by Samuel John

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel John. The network helps show where Samuel John may publish in the future.

Co-authorship network of co-authors of Samuel John

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel John. A scholar is included among the top collaborators of Samuel John based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel John. Samuel John is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Mi, Xiaoye Liu, Ryan Huang, et al.. (2025). Eph Receptors Activate Myeloid Checkpoint Receptor LILRB5 to Support Tumor Development. Cancer Immunology Research. 13(6). 821–835. 1 indexed citations
2.
Pal, Subhajit, Haoying Sun, Yuefeng Nie, et al.. (2025). Subsecond optically controlled domain switching in freestanding ferroelectric BaTiO3 membrane. Nature Communications. 16(1). 7940–7940. 2 indexed citations
3.
Zheng, Ruifang, Jeffrey Gagan, Giovanni A. Botten, et al.. (2025). Genomic Landscape of Mixed Phenotype Acute Leukemia Associated With Immunophenotypic Lineage Predominance: Impact on Diagnosis and Treatment. European Journal Of Haematology. 114(6). 1041–1051. 2 indexed citations
4.
Myers, Regina M., Yimei Li, Adam J. Lamble, et al.. (2025). Clinical Factors Associated with Prolonged Cytopenias in Children and Young Adults Treated with CD19-Directed CAR T Cells (CAR19) for Acute Lymphoblastic Leukemia. Transplantation and Cellular Therapy. 31(2). S96–S96.
5.
Fuda, Franklin, Flavia Rosado, Samuel John, et al.. (2024). Clinicopathologic features of relapsed CD19(−) B‐ALL in CD19‐targeted immunotherapy: Biological insights into relapse and LILRB1 as a novel B‐cell marker for CD19(−) B lymphoblasts. International Journal of Laboratory Hematology. 46(3). 503–509. 1 indexed citations
6.
7.
John, Samuel, et al.. (2024). High-quality factor Quasi-BIC mode via selective symmetry-breaking approach in a terahertz metasurface. New Journal of Physics. 26(6). 63024–63024. 4 indexed citations
8.
9.
Meo, Francesco Di, Samuel John, Chengcheng Zhang, Ciara L. Freeman, & Fabiana Perna. (2023). Chimeric Antigen Receptor T Cells Targeting LILRB4, an Immunoreceptor Mediating T-Cell Suppression, Are Potently Effective in Multiple Myeloma. Blood. 142(Supplement 1). 4804–4804. 3 indexed citations
10.
Fuda, Franklin, et al.. (2022). Rare circulating lymphoblasts with striking eosinophilia: A rare case of B‐lymphoblastic leukemia with PAX5::ZCCHC7. American Journal of Hematology. 98(6). 989–990. 2 indexed citations
11.
Smith, Caroline, Ryan Huang, Jingjing Xie, et al.. (2022). LILRB4 Is a Novel Target for KMT2A Rearranged Acute Leukemia. Blood. 140(Supplement 1). 7423–7424. 3 indexed citations
12.
13.
Wu, Guojin, Yixiang Xu, Robbie D. Schultz, et al.. (2021). LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2–cFLIP–NF-κB signaling axis. Nature Cancer. 2(11). 1170–1184. 38 indexed citations
14.
Deng, Mi, Heyu Chen, Xiaoye Liu, et al.. (2021). Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer. PubMed. 4(1). 16–33. 37 indexed citations
15.
Boyer, Michael W., Sonali Chaudhury, Kara L. Davis, et al.. (2021). ALL-026: Evaluating Efficacy and Safety of Tisagenlecleucel Reinfusion Following Loss of B-Cell Aplasia in Pediatric and Young Adult Patients with Acute Lymphoblastic Leukemia: HESTER Phase II Study. Clinical Lymphoma Myeloma & Leukemia. 21. S262–S263. 1 indexed citations
16.
17.
Churchill, Hywyn, Franklin Fuda, Jing Xu, et al.. (2020). Leukocyte immunoglobulin‐like receptor B1 and B4 (LILRB1 and LILRB4): Highly sensitive and specific markers of acute myeloid leukemia with monocytic differentiation. Cytometry Part B Clinical Cytometry. 100(4). 476–487. 14 indexed citations
18.
Pacenta, Holly, Theodore W. Laetsch, & Samuel John. (2019). CD19 CAR T Cells for the Treatment of Pediatric Pre-B Cell Acute Lymphoblastic Leukemia. Pediatric Drugs. 22(1). 1–11. 8 indexed citations
19.
John, Samuel, Heyu Chen, Mi Deng, et al.. (2018). A Novel Anti-LILRB4 CAR-T Cell for the Treatment of Monocytic AML. Molecular Therapy. 26(10). 2487–2495. 97 indexed citations
20.
John, Samuel, et al.. (2008). The Gravity of Regenerative Medicine; Physics, Chemistry & Biology behind it.. PubMed. 4(1). 22–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosanna M. McEwen-Smith Breakdown of academic impact, for papers by Giulia Barbarito Breakdown of academic impact, for papers by Tina Nuebling Breakdown of academic impact, for papers by Soyoko Morimoto Breakdown of academic impact, for papers by Haven R. Garber Breakdown of academic impact, for papers by Jine Zheng Breakdown of academic impact, for papers by Guillermo O. Rangel Rivera Breakdown of academic impact, for papers by Susann Rahmig Breakdown of academic impact, for papers by Kirsten Nikolajsen Breakdown of academic impact, for papers by Kyogo Suzuki
Rankless by CCL
2026